A new clinical trial listing for mazdutide appeared on ClinicalTrials.gov dated September 17, 2026. The study is titled "Mazdutide for Weight Management and Gout in Adults With Obesity" and is registered under identifier NCT07824895.
The trial is designated Phase 4 and its current status is listed as not yet recruiting. According to the registry entry, this means the study has not begun enrolling participants as of the listing date.
No results, outcomes, or efficacy data have been posted for this trial at this stage. The event data available covers only the trial's registration details, phase designation, and recruitment status. Mazdutide remains an unapproved compound used in research settings according to its current regulatory status.
Further updates on enrollment, trial progress, or results would be expected as the study advances through subsequent stages. Readers interested in more background may consult the compound overview for additional context on mazdutide.